Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.2B | 2.3B | 2.3B |
Cost of revenue | 1.0B | 1.0B | 1.1B | 1.0B |
Gross profit | 1.3B | 1.2B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 83M | 84M | 72M | 77M |
Other operating expenses | 609M | 620M | 648M | 654M |
Operating income | 651M | 483M | 527M | 555M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 97M | 106M | 103M | 105M |
Other income expense | -747M | -478M | 134M | 16M |
Pretax income | -193M | -101M | 558M | 466M |
Tax provision | -34M | -41M | 51M | 126M |
Net income | -159M | -60M | 507M | 340M |
Basic EPS | -0.6 | — | 1.9 | 1.3 |
Diluted EPS | -0.6 | — | 1.9 | 1.3 |
Basic average shares | 260.4M | — | 262.1M | 266.2M |
Diluted average shares | 260.4M | — | 264M | 268.1M |
EBITDA | 1.2B | 1.0B | 1.3B | 1.1B |
Net income from continuing op. | -159M | -60M | 507M | 340M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |